Avidity’s Delpacibart Gets Japan Orphan Drug Statu...
Category : ODD/BTA/FTA Status 11 April 2025Avidity Biosciences, Inc, a biopharmaceutical company committed to delivering a new class of RNA the...
Odd Bta Fta Status
Sanofi’s Rilzabrutinib Gets FDA Orphan Drug Status...
Category : ODD/BTA/FTA Status 7 April 2025The US Food and Drug Administration (FDA) has granted orphan drug designation to rilzabrutinib, an i...
China NMPA grants breakthrough therapy status to I...
Category : ODD/BTA/FTA Status 2 April 2025Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufact...
US FDA grants fast track designation to Sanofi’s m...
Category : ODD/BTA/FTA Status 29 March 2025The US Food and Drug Administration (FDA) has granted fast track designation to Sanofi’s mRNA...
FDA Grants Fast Track to J&J’s Nipocalimab for Sjö...
Category : ODD/BTA/FTA Status 20 March 2025Johnson & Johnson announced that the US Food and Drug Administration (FDA) has granted investiga...
Latest Newsletter Post
-
InnoCare Wins OK to Trial BCL2 Drug..
30 May 2025
-
Biogen partners with City Therapeut..
30 May 2025
-
China NMPA Grants Priority Review t..
30 May 2025
-
Immutep’s efti combo hits Phase II..
30 May 2025
-
Lilly to expand its pain pipeline w..
29 May 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com